CN117694461B - Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor - Google Patents

Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor Download PDF

Info

Publication number
CN117694461B
CN117694461B CN202410035631.0A CN202410035631A CN117694461B CN 117694461 B CN117694461 B CN 117694461B CN 202410035631 A CN202410035631 A CN 202410035631A CN 117694461 B CN117694461 B CN 117694461B
Authority
CN
China
Prior art keywords
choline
cyclopentene
dione
angelic acid
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202410035631.0A
Other languages
Chinese (zh)
Other versions
CN117694461A (en
Inventor
金巍
沈宏
占小秀
谢斐
毛胜勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Agricultural University
Original Assignee
Nanjing Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Agricultural University filed Critical Nanjing Agricultural University
Priority to CN202410035631.0A priority Critical patent/CN117694461B/en
Publication of CN117694461A publication Critical patent/CN117694461A/en
Application granted granted Critical
Publication of CN117694461B publication Critical patent/CN117694461B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)

Abstract

本发明公开了当归酸和/或4‑环戊烯‑1,3‑二酮在制备胆碱降解抑制剂中的应用。本发明首次发现当归酸和4‑环戊烯‑1,3‑二酮可抑制胃肠道微生物对胆碱的降解,作为饲料添加剂在抑制胆碱降解的同时,4‑环戊烯‑1,3‑二酮还可提高饲料利用率。The present invention discloses the use of angelic acid and/or 4-cyclopentene-1,3-dione in the preparation of a choline degradation inhibitor. The present invention firstly finds that angelic acid and 4-cyclopentene-1,3-dione can inhibit the degradation of choline by gastrointestinal microorganisms. As a feed additive, 4-cyclopentene-1,3-dione can inhibit the degradation of choline and improve feed utilization.

Description

Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor
Technical Field
The invention relates to application of angelic acid and/or 4-cyclopentene-1, 3-dione in inhibiting gastrointestinal tract microorganism from degrading choline, belonging to the field of compound application.
Background
Choline is an essential nutrient for animals and can affect various physiological processes of the liver, such as lipid and cholesterol metabolism. Although the liver can produce some choline, choline is mainly obtained from feed. Studies have shown that reduced choline levels induce fatty liver disease by reducing the efflux of very low density lipoproteins from hepatocytes. Choline is critical to perinatal cows. Perinatal cows generally have reduced incidence of fatty liver and ketosis by feeding ruminally protected choline chloride. However, gastrointestinal microorganisms rapidly degrade choline in feed to trimethylamine, resulting in reduced bioavailability of choline by animals, which may be associated with fatty liver or ketosis in some of the cows. In addition, trimethylamine and its metabolite in liver oxidize trimethylamine to have toxic effect on animals and harm animal health. Trimethylamine is also an important substance that causes animal products to develop fishy smell. However, there is currently no choline degradation inhibitor suitable for animal use.
Disclosure of Invention
The first object of the invention is to provide the application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparing choline degradation inhibitors. The second object of the present invention is to provide the use of angelic acid and/or 4-cyclopentene-1, 3-dione in the preparation of feed additives.
The technical scheme is that the application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparing choline degradation inhibitors.
The choline degradation inhibitor comprises angelic acid and/or 4-cyclopentene-1, 3-dione. The invention relates to an application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparing a feed additive, wherein the feed additive is used for inhibiting degradation of choline in gastrointestinal tracts.
Wherein the feed additive is used for reducing the content of trimethylamine oxide and trimethylamine in livestock blood.
Wherein the livestock comprises one of ruminants, monogastric animals and birds.
The active ingredients of the feed additive are angelic acid and/or 4-cyclopentene-1, 3-dione.
Wherein the feed additive is used for reducing fishy smell of livestock products caused by trimethylamine.
Wherein the 4-cyclopentene-1, 3-dione is used for improving the utilization rate of the feed.
Compared with the prior art, the invention has the remarkable advantages that the invention discovers that the angelic acid and the 4-cyclopentene-1, 3-dione can inhibit the degradation of choline by gastrointestinal microorganisms for the first time, and can also improve the utilization rate of the feed when being used as a feed additive to inhibit the degradation of choline in animal gastrointestinal tracts.
Detailed Description
The technical scheme of the invention is further described below with reference to the specific technical scheme.
Example 1
1. Materials and methods
1.1 Strain and Medium and preparation
1.1.1 Strain
The choline degrading bacteria used in this study were ESCHERICHIA FERGUSONII ATCC 35469.
1.1.2 Medium and configuration
The medium composition is shown in Table 1.
TABLE 1 Medium composition (1.0L)
The preparation method of the reagent comprises the following steps:
The preparation of the gastric juice without cytoma comprises filtering rumen juice with two layers of gauze to remove large granule residues, centrifuging filtrate at 12,000rpm/min at 4deg.C for 20min, collecting supernatant, and storing at-20deg.C for use.
The microelement solution is prepared by dissolving nitrilotriacetic acid (nitrilotriacetic acid)(1.5g)、NaCl(1.0g)、NaMoO4·2H2O(0.01g)、NaSeO4(0.19g)、Na2WO4·2H2O(0.1g)、MgSO4·7H2O(3.0g)、AlK(SO4)2·12H2O(0.018g)、CoSO4·7H2O(0.18g)、CaCl2·2H2O(0.1g)、ZnSO4·7H2O(0.18g)、FeSO7H2O(0.1g)、MnSO4.H2O(0.45g)、NiSO4·6H2O(0.1g)、CuSO4·5H2O(0.01g)、H3BO3(0.01g) in 1L deionized water.
The preparation of fatty acid solution comprises the steps of weighing 8.0g of NaOH, dissolving in 800mL of deionized water, adding 6.85mL of acetic acid, 3.00mL of propionic acid, 1.84mL of butyric acid and 0.55mL of valeric acid, adding a proper amount of deionized water to a constant volume to 1L, and preserving at 4 ℃ for later use.
The preparation of vitamin solution comprises weighing 54.7g KH 2PO4, dissolving in 1L deionized water, sequentially adding 20.4mg biotin, 20.4mg folic acid, 164mg calcium pantothenate, 164mg nicotinamide, 164mg riboflavin, 164mg thiamine hydrochloride, 164mg vitamin B6 hydrochloride, 20.4mg para-aminobenzoic acid and 20.5mg cobalamin, filtering, sterilizing, packaging in anaerobic tube, and preserving at 4deg.C for use.
1.1.3 Preparation of Medium
The preparation (1L) of anaerobic culture medium comprises accurately measuring each component in wide-bottom flask according to the culture medium formula, adding deionized water to make up 1L, heating and boiling in a microwave oven until the liquid changes from blue to red, rapidly taking out, immediately introducing carbon dioxide for about 2h, then adding L-cysteine hydrochloride until the liquid becomes clear, packaging, introducing carbon dioxide in advance to remove air in a fermentation tube, adding 9.6mL of culture medium, sealing the bottle mouth with a rubber plug, sealing with an aluminum cap, placing into an autoclave for sterilization, and cooling for later use.
1.2 Design of experiments
Angelic acid solution or 4-cyclopentene-1, 3-dione was added to the fermenter respectively in the amounts shown in Table 2,4 replicates per group. 20.0mmol/L choline is added into each fermentation tube as a substrate, and the bacterial liquid which is cultivated until the logarithmic phase is inoculated into a culture medium which is injected with 0.1mL of vitamin solution and angelic acid solution/4-cyclopentene-1, 3-dione in advance, wherein the inoculation amount is 3.0 percent, and the bacterial liquid is cultivated for 60 hours at 39 ℃ and 50 rpm/min.
The amount of inhibitor added (final concentration) in Table 2
1.3 Sample collection and index determination
1.3.1 Growth Curve drawing
At the end of fermentation, the absorbance (OD value) of the bacteria liquid in the fermentation tube after shaking was measured by a spectrophotometer at a wavelength of 600 nm.
1.3.2 Choline concentration determination
1.0ML of the fermentation broth was centrifuged at 13000 Xg at 4℃for 2min, and the supernatant was collected. Concentration was measured using a bovine choline ELISA assay kit (Emblica Corp., china) and the test procedure was described in the specification.
1.4 Statistical processing of data
Data were analyzed using One-way ANOVA (Tukey) in SPSS20.0 software, P <0.05 indicated significant differences.
2. Results
As shown in tables 3 and 4, angelic acid and 4-cyclopentene-1, 3-dione can inhibit ESCHERICHIA FERGUSONII degradation of choline in a targeting manner, and can inhibit choline degradation under certain concentration conditions, but basically does not influence microbial growth.
TABLE 3 Effect of angelic acid on ESCHERICHIA FERGUSONII degradation of choline
Note that the shoulder marks of the same row of data show insignificant differences (P > 0.05), the different letters show significant differences (P < 0.05), the initial concentration of choline is 20.0mmol/L, and the four concentrations of angelic acid have no effect on the degradation of choline without adding ESCHERICHIA FERGUSONII (19.6, 19.8, 19.9, 19.5 mmol/L).
TABLE 4 influence of 4-cyclopentene-1, 3-dione on ESCHERICHIA FERGUSONII degradation of choline
Note that the shoulder marks of the same row of data show insignificant differences (P > 0.05), the different letters show significant differences (P < 0.05), the initial concentration of choline is 20.0mmol/L, and 4-cyclopentene-1, 3-dione at four concentrations has no effect on the degradation of choline without adding ESCHERICHIA FERGUSONII (19.5, 19.8, 19.7, 19.5 mmol/L).
Example 2
1 Material method
1.1 Experimental materials
1.1.1 Test animals and rumen fluid collection
The test animals were raised at the university of Nanjing agriculture animal science and technology college dairy cow test base (Nanjing, jiangsu), 3 Holstein cows with permanent rumen fistula had an average body weight of 613+ -35 kg. On the day of the test, rumen fluid was taken half an hour before morning feeding and quickly returned to the laboratory in a vacuum flask that had been pre-filled with carbon dioxide.
1.1.2 Preparation of Artificial rumen fermentation broth
The collected fresh rumen fluid is filtered by 4 layers of gauze, and the rumen fluid and buffer solution (specific components are shown in table 5) are mixed according to the proportion of 1:9 (v/v) to prepare the mixed artificial rumen culture fluid. The mixed fermentation liquor is packaged into 180mL fermentation bottles, the temperature in the whole process is kept at 39 ℃, pure carbon dioxide is continuously introduced to keep anaerobic environment, and a magnetic stirrer is used for stirring to keep the rumen liquor and the buffer solution uniformly mixed. 1g of straw powder and inhibitor (angelic acid or 4-cyclopentene-1, 3-dione) are added into a fermentation bottle in advance, and are placed into a constant temperature incubator at 39 ℃ for preheating for 30min. After the completion of the split charging, the culture was carried out at 39℃and 80r/min for 72 hours in a constant temperature shaker.
TABLE 5 buffer composition (1L)
Preparing a specific solution:
(1) Microelement solution (A liquid)
Deionized water was added to 100mL
(2) Buffer solution (liquid B)
NH4HCO3 4.0g
NaHCO3 35.0g
Deionized water was added to 1000mL
(3) Macroelement solution (C liquid)
Na2HPO4·12H2O 9.45g
KH2PO4 6.2g
MgSO4·7H2O 0.6g
Deionized water was added to 1000mL
(4) 0.1% Resazurin solution (solution D)
100Mg of resazurin was added to 100mL of deionized water.
(5) Reducing agent solution (E liquid)
1.2 Test methods
1.2.1 Test design
Example 1 test set 4 groups.
1. Treatment group 1, no drug added.
2. Treatment group 2 angelic acid 1.8mmol/L.
3. Treatment group 3 angelic acid 3.6mmol/L.
4. Treatment group 4 angelic acid 7.2mmol/L.
5. Treatment group 5 4-cyclopentene-1, 3-dione 1.8mmol/L.
6. Treatment group 6 4-cyclopentene-1, 3-dione 3.6mmol/L.
7. Treatment group 7:4-cyclopentene-1, 3-dione 7.2mmol/L
1.2.2 Chemical analysis
And (3) measuring the total gas production, namely measuring the gas production in the fermentation bottle by using a gas pressure converter.
Choline concentration was measured by taking 1.0mL of the fermentation broth, centrifuging at 13000 Xg at 4℃for 2min, and taking the supernatant. Concentration was measured using a bovine choline ELISA assay kit (Emblica Corp., china) and the test procedure was described in the specification.
1.3 Statistical data processing
Data were analyzed using One-way ANOVA (Tukey) in SPSS20.0 software, P <0.05 indicated significant differences.
2. Results
As shown in tables 6 and 7, in the rumen in vitro simulated fermentation, angelic acid (7.2 mmol/L) and 4-cyclopentene-1, 3-dione (1.8-7.2 mmol/L) can inhibit the degradation of choline. Except that angelic acid reduced gas production and 4-cyclopentene-1, 3-dione increased gas production.
TABLE 6 Effect of angelic acid on degradation of choline by rumen in vitro fermentation
Note that the same row of data shoulder marks have no letters indicating that the difference is not significant (P > 0.05), and different letters indicating that the difference is significant (P < 0.05).
TABLE 7 influence of 4-cyclopentene-1, 3-dione on degradation of choline by rumen in vitro fermentation
Note that the same row of data shoulder marks have no letters indicating that the difference is not significant (P > 0.05), and different letters indicating that the difference is significant (P < 0.05).
The results show that the angelic acid and the 4-cyclopentene-1, 3-dione can protect choline in the ration from being degraded by rumen flora, and meanwhile, the 4-cyclopentene-1, 3-dione can also improve the utilization rate of the rumen flora on the substrate.

Claims (4)

1.当归酸和/或4-环戊烯-1,3-二酮在制备胆碱降解抑制剂中的应用。1. Application of angelic acid and/or 4-cyclopentene-1,3-dione in the preparation of choline degradation inhibitors. 2.当归酸和/或4-环戊烯-1,3-二酮在制备饲料添加剂中的应用,其特征在于,所述饲料添加剂用于抑制胆碱在胃肠道中的降解。2. Use of angelic acid and/or 4-cyclopentene-1,3-dione in the preparation of a feed additive, characterized in that the feed additive is used to inhibit the degradation of choline in the gastrointestinal tract. 3.根据权利要求2所述的应用,其特征在于,所述饲料添加剂用于降低家畜血液中氧化三甲胺和三甲胺含量。3. The use according to claim 2, characterized in that the feed additive is used to reduce the content of trimethylamine oxide and trimethylamine in the blood of livestock. 4.根据权利要求3所述的应用,其特征在于,所述家畜包括反刍动物、单胃动物中的一种。4. The use according to claim 3, characterized in that the livestock comprises one of ruminants and monogastric animals.
CN202410035631.0A 2024-01-10 2024-01-10 Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor Active CN117694461B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410035631.0A CN117694461B (en) 2024-01-10 2024-01-10 Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410035631.0A CN117694461B (en) 2024-01-10 2024-01-10 Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor

Publications (2)

Publication Number Publication Date
CN117694461A CN117694461A (en) 2024-03-15
CN117694461B true CN117694461B (en) 2025-04-08

Family

ID=90153418

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410035631.0A Active CN117694461B (en) 2024-01-10 2024-01-10 Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor

Country Status (1)

Country Link
CN (1) CN117694461B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102326714A (en) * 2011-09-28 2012-01-25 山东农业大学 Ruminant rumen by-pass coating material and application thereof in choline coating
CN102630817A (en) * 2011-02-14 2012-08-15 河北农业大学 Rumen-protected choline chloride microcapsule additive and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037484A1 (en) * 2005-09-30 2007-04-05 Kaneka Corporation Curable composition
US20080160116A1 (en) * 2006-12-07 2008-07-03 Herbalscience Singapore Pte. Ltd Compositions and Methods Comprising Zingiber Species
CN102885207B (en) * 2012-11-07 2013-11-06 成都大帝汉克生物科技有限公司 Composite cheese liver flavor attractant and preparation method thereof
KR102119178B1 (en) * 2017-10-12 2020-06-04 주식회사 이앤사이언스 Immune-enhancing composition comprising fermented-Angelica gigas extract as effective component

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102630817A (en) * 2011-02-14 2012-08-15 河北农业大学 Rumen-protected choline chloride microcapsule additive and preparation method thereof
CN102326714A (en) * 2011-09-28 2012-01-25 山东农业大学 Ruminant rumen by-pass coating material and application thereof in choline coating

Also Published As

Publication number Publication date
CN117694461A (en) 2024-03-15

Similar Documents

Publication Publication Date Title
CN102154167B (en) Mycoplasma hyopneumoniae culture medium and preparation method thereof
CN114085789B (en) Pediococcus pentosaceus MA.WTPQJ01 and application thereof
CN116083273B (en) Lactobacillus plantarum NHE-LpE and application thereof
CN113862196B (en) Bacillus subtilis SD-KC-001 and application thereof
CN112574924A (en) Bacillus subtilis strain, microecological preparation and application thereof
CN113322213A (en) Lactobacillus paracasei Jlus66 microbial inoculum with function of improving dysmnesia and application
CN108728375A (en) The in vitro culture and store method of cow rumen flora
CN108949619A (en) A kind of zymotechnique of riemerella anatipestifer
CN117694461B (en) Application of angelic acid and/or 4-cyclopentene-1, 3-dione in preparation of choline degradation inhibitor
CN110093288B (en) Quick-fermentation composite probiotic regulator for improving water quality of aquaculture farm
CN115491329A (en) Breast milk source lactobacillus plantarum HM-P2 and application thereof
CN115261287A (en) Composite lactobacillus microbial inoculum and application thereof
CN107043724B (en) A kind of Bacillus licheniformis and its separation method and application
CN1317385C (en) Cheese lactobacillus Bd-II strain and use for decreasing blood fat
CN107012095B (en) Fermentation parameters for in vitro simulated culture of porcine colon microorganisms
CN118126909B (en) Lactobacillus reuteri and application thereof in helicobacter pylori resistance
CN106190913A (en) One strain Rhodopseudomonas palustris and store method thereof
CN117899121A (en) Biological agent for preventing and treating riemerella anatipestifer as well as preparation method and application thereof
CN115992066B (en) Lactobacillus paracasei NHB-LpD2 for liquid fermented feed and application
RU2518304C2 (en) TWO-PHASE NUTRITIONAL MEDIUM FOR THIN LAYER CULTIVATION OF Helicobacter pylori AND METHOD OF ITS REALISATION
CN114317344B (en) Enterococcus faecium and application thereof, composition and fermentation culture method of enterococcus faecium
CN117660218A (en) Lactobacillus reuteri LR108 strain capable of improving obesity of dogs and cats and application thereof
CN116948861A (en) Strain with anti-aging function and application thereof
CN110257299B (en) Application of a kind of Enterobacter cloacae in promoting the growth of ruminants
CN116083274A (en) Pediococcus acidilactici NHB-PaA4 for liquid fermentation feed and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant